Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Eli Lilly

Eli Lily caps the cost of insulin at $35 a month, bringing relief to millions of Americans.

As insulin prices have soared, this manufacturer announces it will reduce costs by 70%.

Fortune

Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocket

The moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.

WEKU

Under pressure, Eli Lilly cuts insulin prices 70%

Drugmaker Eli Lilly says it's cutting the price of one insulin to below 1990s levels.

Axios

From analysis to the latest developments in health,
read the most diverse news in one place.

Lilly plans to slash some insulin prices, expand cost cap

Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay when they fill prescriptions

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

When Mounjaro came on the market, TikTok went wild. People with obesity ordered the drug in droves thanks to a coupon that allowed them to access it for just $25 a month. Then the coupon went away, leaving destruction in its wake — and obese patients warring with diabetics. Emily…

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

The ‘next Ozempic’ became a social media sensation. Then everything changed

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

The Independent UK

Armed with hashtags, these activists made insulin prices a presidential talking point

Hannah Crabtree got active on Twitter in 2016 to find more people like herself: those with Type 1 diabetes who’d hacked their insulin pumps to automatically adjust the amount of insulin delivered.

Tribune News Service

Ignore the ‘superpower’ boasts – UK pharma looks superchallenged

NHS crisis, withdrawal of tax credits and exit from EU blamed for fall in UK share of R&D market

The Guardian - UK

Lilly shares slip as FDA seeks more Alzheimer's drug data

Eli Lilly shares slipped Friday morning after regulators said they need to see more data on the company’s application for a quick approval of its potential Alzheimer’s disease treatment

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

Drugmakers sued over insulin prices

California's Attorney General Rob Bonta sued the six major companies that dominate the U.S. insulin market

The Independent UK

California latest to sue drug companies over insulin prices

California says it will sue the companies that make and promote much of the nation's insulin

Axios

2023 could be a banner year for prescription drugs

There's a large pipeline of promising yet expensive drugs that could get approved.

Fortune

Tesla share plunge puts market cap behind LVMH, Nvidia, Eli Lilly

Tesla shares fell 12.2% on Tuesday after missing expectations on fourth-quarter deliveries.

Get all your
news in one place.

100's of premium titles.
One news app.

Axios

The growing market for weight loss drugs

A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.

The Independent UK

Twitter to re-launch blue tick subscription service after first chaotic rollout backfired

The platform’s Blue subscriptions will return with $8 monthly charges, or $11 a month for iPhone users

Fortune

Top executives explain how they achieve ESG goals amid backlash

How should companies reframe ESG initiatives amid controversy? These executives offer their strategies.

WEKU

Twitter has lost 50 of its top 100 advertisers since Elon Musk took over, report says

Half of Twitter's top 100 advertisers appear to no longer be advertising on the website. A new report states that these 50 advertisers have spent almost $2 billion on Twitter ads since 2020.

The Conversation

Elon Musk's Twitter Blue fiasco: Governments need to better regulate how companies use trademarks

Until recently, Twitter’s blue checkmark logo was (for better or worse) a trusted mark of authenticity. But under the façade of democratizing the platform, Elon Musk allowed the blue checkmark to be purchased by anyone — with unsurprisingly chaotic results.

The Guardian - US

‘More work to do’: Eli Lilly admits insulin pricing could be lower amid Twitter chaos

Furor over platform’s verified profiles may have done some good, but challenges still plague the site after a mass worker exodus

The Conversation

Impersonation and parody: Shitposters satirically mock Elon Musk’s chaotic Twitter takeover

Posting on Twitter has changed since Elon Musk finalized his $44 billion takeover of the micro-blogging platform.

1 … 23 24 25 26

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.